119 related articles for article (PubMed ID: 7607571)
21. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
22. An improved method for semiquantification of gene amplification from archival material.
Underwood MA; Bartlett JM; Cooke TG
PCR Methods Appl; 1994 Dec; 4(3):178-84. PubMed ID: 7580903
[TBL] [Abstract][Full Text] [Related]
23. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
Friedrichs K; Lohmann D; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction.
Gramlich TL; Cohen C; Fritsch C; DeRose PB; Gansler T
Am J Clin Pathol; 1994 Apr; 101(4):493-9. PubMed ID: 7909190
[TBL] [Abstract][Full Text] [Related]
25. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.
Vogt U; Bielawski K; Schlotter CM; Bosse U; Falkiewicz B; Podhajska AJ
Gene; 1998 Nov; 223(1-2):375-80. PubMed ID: 9858771
[TBL] [Abstract][Full Text] [Related]
26. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
27. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
28. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
[TBL] [Abstract][Full Text] [Related]
29. ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women.
Vaidyanathan K; Kumar P; Reddy CO; Deshmane V; Somasundaram K; Mukherjee G
Indian J Cancer; 2010; 47(1):8-15. PubMed ID: 20071783
[TBL] [Abstract][Full Text] [Related]
30. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
[TBL] [Abstract][Full Text] [Related]
31. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
32. A differential PCR assay for the detection of c-erbB 2 amplification used in a prospective study of breast cancer.
Jennings BA; Hadfield JE; Worsley SD; Girling A; Willis G
Mol Pathol; 1997 Oct; 50(5):254-6. PubMed ID: 9497915
[TBL] [Abstract][Full Text] [Related]
33. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
[TBL] [Abstract][Full Text] [Related]
34. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
35. Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma.
Ali IU; Campbell G; Lidereau R; Callahan R
Oncogene Res; 1988 Sep; 3(2):139-46. PubMed ID: 3226722
[TBL] [Abstract][Full Text] [Related]
36. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.
Brown DN; Caffa I; Cirmena G; Piras D; Garuti A; Gallo M; Alberti S; Nencioni A; Ballestrero A; Zoppoli G
Sci Rep; 2016 Jan; 6():19435. PubMed ID: 26777065
[TBL] [Abstract][Full Text] [Related]
37. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
[TBL] [Abstract][Full Text] [Related]
39. Molecular and immunohistochemical study of class I growth factor receptors in squamous cell lung carcinomas.
Gorgoulis V; Sfikakis PP; Karameris A; Papastamatiou H; Trigidou R; Veslemes M; Spandidos DA; Sfikakis P; Jordanoglou J
Pathol Res Pract; 1995 Oct; 191(10):973-81. PubMed ID: 8838364
[TBL] [Abstract][Full Text] [Related]
40. Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
Hubbard AL; Doris CP; Thompson AM; Chetty U; Anderson TJ
Br J Cancer; 1994 Sep; 70(3):434-9. PubMed ID: 7915911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
